Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 902917, 14 pages
http://dx.doi.org/10.1155/2012/902917
Review Article

Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases

1Department of Microbiology & Immunology, National Institute of Nutrition, Hyderabad 50007, India
2Shaheed Udham Singh College of Research & Technology, Punjab, Mohali, Radaur, Haryana, India
3Research and Development Unit, National Heart Centre, 1687521, Singapore
4Department of Zoology, M.L.K. Post-Graduate College, Balrampur 271201, India
5Department of Biotechnology, ITS Paramedical College, Ghaziabad 201206, India
6Indian Veterinary Research Institute, Regional Station, Palampur 176061, India
7Hepato-Gastroenterology Unit, S. Giuseppe Hospital, Vittore, 20123 Milano, Italy
8Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
9Endocrinology, Diabetes, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Received 18 October 2011; Accepted 10 January 2012

Academic Editor: Raffaele Marfella

Copyright © 2012 Manoj Kumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Manoj Kumar, Ravinder Nagpal, Rajesh Kumar, et al., “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases,” Experimental Diabetes Research, vol. 2012, Article ID 902917, 14 pages, 2012. https://doi.org/10.1155/2012/902917.